Ramazonbek Temirov won’t be eligible to return to Ultimate Fighting Championship competition until next summer after testing positive for a banned substance earlier this year.
Combat Sports Anti-Doping revealed on Wednesday that the flyweight tested positive for Trimetazidine (TMZ) in out-of-competition samples collected on June 12 and July 4 in Phuket, Thailand. TMZ, which is used to treat heart failure and other cardiac conditions, is listed as a hormone and metabolic modulator on the UFC’s prohibited list. Because Temirov was not notified of the positive test on June 12 until after the July 4 sample was collected, they are combined into one anti-doping violation.